4D-printed microneedles from dual-sensitive chitosan for non-transdermal drug delivery

Int J Biol Macromol. 2024 Mar;261(Pt 2):129638. doi: 10.1016/j.ijbiomac.2024.129638. Epub 2024 Jan 23.

Abstract

Microneedles are a promising micro-scale drug delivery platform that has been under development for over two decades. While 3D printing technology has been applied to fabricate these systems, the challenge of achieving needle sharpness remains. In this study, we present an innovative approach for microneedle fabrication using digital light processing (DLP) 3D printing and smart chitosan biomaterial. For the first time, we used hydroxybutyl methacrylated chitosan (HBCMA), which possesses dual temperature- and photo-sensitive properties, to create microneedles. The DLP approach enabled a quick generation of HBCMA-based microneedles with a high resolution. The microneedles exhibited 4D properties with a change in needle dimensions upon exposure to temperature, which enhances resolution, sharpens needles, and improves mechanical strength. We demonstrated the ability of these microneedles to load, deliver, sustained release small molecular drugs and penetrate soft tissue. Overall, the HBCMA-based microneedles show promising potential in non-dermal drug delivery applications.

Keywords: 4D printing; Digital light processing; Hydrogel; Hydroxybutyl methacrylate chitosan; Microneedles.

MeSH terms

  • Administration, Cutaneous
  • Chitosan*
  • Delayed-Action Preparations
  • Drug Delivery Systems / methods
  • Microinjections / methods

Substances

  • Chitosan
  • Delayed-Action Preparations